Radar › Companies › Biopharma Outsourcing · Washington
Radar · Biopharma Outsourcing in Washington

Best Biopharma Outsourcing Companies in Washington, United States

The 30 best Biopharma Outsourcing companies in Washington, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Just Biotherapeutics.

30companies tracked
$520.8Mdisclosed funding
0unicorns
12have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × WASHINGTON

Our analysis of 50 Biopharma Outsourcing companies

$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
77%cloud-native stacks
2025funding peak (by rounds)
2018median founding year
45median Fliar Index™
95kcombined LinkedIn audience
64%of audience held by top 3
2companies hiring publicly (12 mo)

Ranked: Best Biopharma Outsourcing companies in Washington

#CompanyDisclosed fundingLast roundStageEmployeesFounderTech stackPatents & IP focusRecent signals
1AGC Biologics
CDMO focused on development of mammalian and microbial-based therapeutic proteins
——Unfunded1,290Patricio Massera
CEO
HubSpot CMS HubApple iCloud MailSalesforce+2020 patents
Recombinant protein expression vectors and continuous high‑density cell culture bioprocessing
—
2Ascensus Specialties
Producer of specialty chemicals
——Acquired248
248 → 161 (-35%)
—Craft CMSPHPSalesforce+12——
3axio research
Axio Research is a pharmaceuticals company specializing in data monitoring services.
——Acquired30————
4cognition studio, inc
Helping life science leaders build trust, draw mission-aligned investors, and focus on human impact.
———45————
5global bioclinical
Global BioClinical specializes in clinical research, project and quality management, trial planning along…
——Private7————
6Jubilant HollisterStier
CDMO offering sterile and non-sterile manufacturing services
——Unfunded1,389—WordPressMySQLPHP+284 patents
Manufacturing concentrated allergen extracts for diagnostic and therapeutic pharmaceutical use
—
7Just-Evotec Biologics
Provider of diversified CDMO services
——Unfunded95——96 patents
Automated biomanufacturing and purification systems for protein therapeutics, including filtration and AI design
—
8Loginov Tech
Provider of software solutions and custom development for multiple industries
——Unfunded—Ilya Loginov
Founder & CEO
———

Top 12 Biopharma Outsourcing companies in Washington

#1
Series B · Seattle, Washington · founded 2020 · 14 employees
$70Mraised
▾

Developer of engineered cell-based therapeutics to restore vision. The company is advancing cell-based therapies and in vivo reprogramming to restore vision loss caused by the deterioration of functional tissue for people with degenerative ocular diseases.

Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 23%
Talent
top 23%
Moat
top 31%
Growth
top 33%
Tech
top 49%
News
top 49%
Funding: Raised $70.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Jan 2026)
Talent: 8 named leaders on record · 8 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Funding rounds
  • Jan 2026Conventional Debt$150M
  • Jan 2026Series B$85M
  • Jul 2023Series A$70M
  • 2021Seed—
Founders & team
Jose SahelCo-FounderLyndon CruzCo-FounderThomas RehCo-Founder
Investors
British Patient Capital, F-Prime Capital, Sofinnova Partners, Qiming, Eight Roads Ventures, UCL Technology Fund
Tech stack
AccessibeAnime.JsCookieyesCore-JsElementorFastly
#2
Series A · Seattle, Washington · founded 2022 · 34 employees
$85Mraised
▾

InduPro is a biotechnology company that focuses on bringing proteins on the cell surface closer together, manipulating their interactions to open up new possibilities for treating various conditions. They have a multidisciplinary team with backgrounds in pharma, academia, and biotech, and they are dedicated to impacting patients' lives through innovative drug development.

Fliar Intelligence Index™ 21how this company ranks against its industry peers
Funding
top 29%
Tech
bottom 40%
Global
bottom 36%
Market
bottom 22%
Funding: Raised $85.0M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) · Last round Series A (Dec 2025)
Tech: 20 technologies across 2/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Http/3
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 4k LinkedIn followers — 4.7% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Lilly) announced in 12 mo
Funding rounds
  • Dec 2025Series A—
  • Jun 2024Series A$85M
Investors
The Column Group, Vida Ventures, MRLV, Emerson Collective, Euclidean Capital, Sanofi
Tech stack
CdnjsCloudflareCloudflare Bot ManagementD3Fullpage.JsGodaddy
#3
Series A · Seattle, Washington · founded 2016 · 14 employees
$72.8Mraised
▾

Limited information available

Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 31%
Global
bottom 48%
Funding: Raised $72.8M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) · Last round Series A (Dec 2024)
Global: Investors from 2 countries beyond United States
Audience (LinkedIn): 2k LinkedIn followers — 2.2% of this cohort's audience
Funding rounds
  • Dec 2024Series A$22.5M
  • Feb 2022Series A$50M
  • May 2019Grant (prize money)$300K
Investors
RA Capital Management, Leaps by Bayer, Myeloma Investment Fund, Vertex Ventures HC, Pontifax, HHS
#4
Series B · Spokane, Washington · founded 2017 · 79 employees
$46.2Mraised
▾

Contract manufacturer of pharmaceuticals

Funding rounds
  • Sep 2023Series B$25M
  • Sep 2020Series B$12.2M
  • Feb 2020Series A$9.1M
Founders & team
Patrick HaffeyFounder
Tech stack
WebflowJqueryLottiefiles
#5
Acquired · Seattle, Washington · founded 2014 · 79 employees
$123.5Mraised
▾

Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs. It designs novel technologies to accelerate biotherapeutic development. It will integrate protein design, process design, and manufacturing plant design to increase translation speed to the clinic and to reduce manufacturing costs. Its services include molecular design, process design, drug product design, and plant design.

Funding rounds
  • Jun 2018Series B$35M
  • Aug 2017Series B$59.5M
  • Jul 2016Series A$14M
  • Sep 2015Series A$15M
Investors
Foundation Equity, Gates, Arch Venture Partners, Lilly Asia Ventures, Merck, Temasek
#6
Acquired · Seattle, Washington · founded 2008 · 160 employees
$67.5Mraised
▾

Provider of trans-formative therapy development and commercialisation services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 10.4% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: leadership_hire
Funding rounds
  • Dec 2018Series D$67.5M
  • Nov 2012Grant (prize money)$675.1K
  • Feb 2012Grant (prize money)$149.5K
  • Feb 2012Grant (prize money)$149.5K
Investors
KKR, Vivo Capital, 5AM Ventures, VenBio, Norwest, HHS
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementDocusignElementorGodaddy
#7
Series A · Issaquah, Washington · founded 2018 · 8 employees
$23.4Mraised
▾

Manufacturer of psychedelic drug discovery & research services. They also offers psychedelic formulations, drug safety, efficacy screening, intellectual property to fund progress, and technological innovation services.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Sep 2021Series A$22M
  • 2020Seed$1.4M
Founders & team
Andrew ChadeayneFounder & CEO
Investors
Noetic Psychedelic Fund, Kortschak Investments, Mont Alto Capital
#8
Seed · Seattle, Washington · founded 2022 · 3 employees
$720Kraised
▾

Developer of AI-driven platform for high-throughput drug screening in live animals. The platform combines robotics, computer vision, and deep learning to automate drug screening. It analyzes movement, behavior, and lifespan in models to quantify therapeutic impact. The system uncovers biological effects and discovers therapeutic candidates.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 1 partnerships · 1 expansions (incl. Rapamycin Longevity Lab) announced in 12 mo
Funding rounds
  • Sep 2024Grant (prize money)$324.2K
  • Jan 2024Seed$720K
Founders & team
Mitchell LeeCo-Founder & CEOJan GruberCo-FounderBrian KennedyCo-Founder
Investors
HHS
Tech stack
Amazon AlbAmazon Web ServicesAstraBackbone.JsClipboard.JsCloudflare
#9
Funding Raised · Seattle, Washington · founded 2005 · 14 employees
$22.6Mraised
▾

Etubics Corporation is developing vaccines utilizing a patented advanced generation adenovirus delivery platform and a validated manufacturing human cell line, collectively the Etubics Platform. The company developing therapeutic vaccines for colorectal, breast, and HPV-induced cancers; preventive vaccines for the treatment of influenza and Ebola. The Company has completed Phase I/IIa clinical trials with its lead product, ETBX-011 (a viral vector against CEA antigen) to treat colorectal cancer.

Funding rounds
  • Sep 2014Grant (prize money)$202.7K
  • May 2014Grant (prize money)$4.4M
  • Apr 2014Grant (prize money)$4.5M
  • Jul 2011Grant (prize money)$1.3M
Investors
NIAID, HHS, Intuitive Venture Partners
#10
Series A · Seattle, Washington · founded 2017 · 10 employees
$6Mraised
▾

Provider of verification services for pharmaceutical products

LinkedIn Pulse recent public activity · Jul 2026
Audience: 621 LinkedIn followers
Funding rounds
  • Feb 2018Series A$5M
  • Oct 2017Seed$1M
Investors
TreeHouse Health
Tech stack
Cart FunctionalitySquarespace CommerceSquarespaceStimulusPriority HintsHsts
#11
Series A · Seattle, Washington · founded 2004 · 15 employees
$3Mraised
▾

Accium BioSciences offers Accelerated Mass Spectrometry (AMS) services such as mass balance ADME, absolute bioavailability, metabolite profiling and microtracing studies (preclinical and clinical) services.The company's key offering includes 14C/12C ratio measurement of clinical samples that support drug development studies.Their AMS facility features a National Electrostatics Corporation 1.5 SDH-1 Pelletron Accelerator Mass Spectrometer that operates with two ion sources of 40-sample and 134-sample capacities and claims to have 0.3% precision and accuracy for all sample measurements. They also offer HPLC chromatography, sample preparation, and method development services. Accium processes clinical samples such as plasma, whole blood, urine, HPLC fractions, processed and unprocessed feces, homogenized tissue, and many other sample types. The company claims that its services are used by five of the top ten global pharmaceutical companies including Merck, Novartis and Bristol-Myers Squibb.

Funding rounds
  • Jan 2006Series A$3M
Founders & team
Glenn KawasakiCEO & President
Investors
Washington Research Foundation
#12
Late Stage · Seattle, Washington · founded 2002 · 96 employees
—raised
▾

CRO focused on providing patient recruitment services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 29k LinkedIn followers — 30.6% of this cohort's audience
Funding rounds
  • Sep 2021PE—
Investors
424 Capital, Eagle Private Capital

Funding & investor landscape

$520.8Mtotal disclosed funding
11companies funded
39disclosed rounds
0rounds last 90 days
Most active investors
HHS4 rounds
Hillhouse2 rounds
424 Capital1 rounds
5AM Ventures1 rounds
ACE & Company1 rounds
AdBio partners1 rounds
Aquilo Partners1 rounds
Arch Venture Partners1 rounds
BOCGI Zheshang Capital1 rounds
Bank of China1 rounds

Notable founders

Jose Sahel
Co-Founder · Tenpoint Therapeutics
Lyndon Cruz
Co-Founder · Tenpoint Therapeutics
Patrick Haffey
Founder · Selkirk Pharma
Andrew Chadeayne
Founder & CEO · CaaMTech
Mitchell Lee
Co-Founder & CEO · Ora Biomedical
Jan Gruber
Co-Founder · Ora Biomedical
Glenn Kawasaki
CEO & President · Accium BioSciences
Prism market signals · United States · country-scoped Prism corpus, 1,368,075 docs

Market landscape — 10 sub-themes by coverage

Share of Biopharma Outsourcing coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Biopharma Outsourcing companies are there in Washington, United States?
Radar tracks 30 indexable Biopharma Outsourcing companies headquartered in Washington, United States that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in Washington, United States?
The Biopharma Outsourcing companies in Washington, United States on this list have raised a combined $520.8M in disclosed equity funding across 11 funded companies.
Which is the highest-funded Biopharma Outsourcing company in Washington, United States?
Just Biotherapeutics is the highest-funded Biopharma Outsourcing company in Washington, United States, with $123.5M in disclosed equity funding.
How many Biopharma Outsourcing companies in Washington, United States are funded?
11 of the 30 Biopharma Outsourcing companies in Washington, United States on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in Washington, United States?
None of the Biopharma Outsourcing companies in Washington, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Washington, United States Biopharma Outsourcing companies?
The most active investors in Washington, United States Biopharma Outsourcing companies on this list include HHS, Hillhouse, 424 Capital, 5AM Ventures, ACE & Company.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon